These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16341336)

  • 1. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town.
    Haque M; Emerson SH; Dennison CR; Navsa M; Levitt NS
    S Afr Med J; 2005 Oct; 95(10):798-802. PubMed ID: 16341336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative study.
    Tan AM; Muthusamy L; Ng CC; Phoon KY; Ow JH; Tan NC
    Singapore Med J; 2011 Nov; 52(11):801-9. PubMed ID: 22173249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do health care professionals assess patients when initiating insulin therapy? A qualitative study.
    Lee PY; Lee YK; Khoo EM; Ng CJ
    Prim Care Diabetes; 2014 Apr; 8(1):49-55. PubMed ID: 24315732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to insulin initiation and intensification and how to overcome them.
    Kunt T; Snoek FJ
    Int J Clin Pract Suppl; 2009 Oct; (164):6-10. PubMed ID: 19751453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambivalence of primary health care professionals towards the South African guidelines for hypertension and diabetes.
    Daniels A; Biesma R; Otten J; Levitt NS; Steyn K; Martell R; Dick J
    S Afr Med J; 2000 Dec; 90(12):1206-11. PubMed ID: 11234651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing barriers to initiation of insulin in patients with type 2 diabetes.
    Peyrot M; Rubin RR; Khunti K
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S11-8. PubMed ID: 20394886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staff knowledge, attitudes and practices in public sector primary care of diabetes in Cape Town.
    Goodman GR; Zwarenstein MF; Robinson II; Levitt NS
    S Afr Med J; 1997 Mar; 87(3):305-9. PubMed ID: 9137343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study.
    Lawton J; Peel E; Parry O; Douglas M
    Diabet Med; 2008 Apr; 25(4):491-5. PubMed ID: 18294222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.
    Ross SA; Tildesley HD; Ashkenas J
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin in general practice - barriers and enablers for timely initiation.
    Furler J; Spitzer O; Young D; Best J
    Aust Fam Physician; 2011 Aug; 40(8):617-21. PubMed ID: 21814661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When oral agents fail: practical barriers to starting insulin.
    Korytkowski M
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S18-24. PubMed ID: 12174319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating insulin in primary care--the role of modern premixed formulations.
    Ligthelm R; Davidson J
    Prim Care Diabetes; 2008 Feb; 2(1):9-16. PubMed ID: 18684415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.
    Cobble ME
    Am J Ther; 2009; 16(1):56-64. PubMed ID: 19142156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK.
    Rubino A; McQuay LJ; Gough SC; Kvasz M; Tennis P
    Diabet Med; 2007 Dec; 24(12):1412-8. PubMed ID: 18042083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration.
    Abu Hassan H; Tohid H; Mohd Amin R; Long Bidin MB; Muthupalaniappen L; Omar K
    BMC Fam Pract; 2013 Oct; 14():164. PubMed ID: 24164794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to help people with diabetes overcome barriers for improved health outcomes.
    Siminerio LM
    Diabetes Educ; 2008; 34 Suppl 1():18S-24S. PubMed ID: 18268002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding barriers to glycaemic control from the patient's perspective.
    Janes R; Titchener J; Pere J; Pere R; Senior J
    J Prim Health Care; 2013 Jun; 5(2):114-22. PubMed ID: 23748392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.